News came out PM the company partnered with a company to advance clinical trials in Ovarian cancer. Stock went from 1.25 to 2.15 at the open. Stayed around the 2 level until just before 10:30 when it squeezed up to 2.50 and later 2.75. Bought the 2.50 BO, spiked the next minute but then bounced back down. Bought more at 1.85. Saw 1.75 as a key level. Sold after it couldn't break 2. Glad I cut it when I did.